EGFR and cancer: Extracellular matrix-receptor interaction (p = 0.03, 8 genes) and regulation of actin cytoskeleton (p = 0.03, 21 genes) were identified as enriched KEGG pathways for hsa-miR-92a-3p, while for hsa-miR-626, enriched pathways include the epidermal growth factor receptor pathway (p = 0.01, 7 genes), oestrogen signalling pathway (p = 0.03, 7 genes) and the phosphatidylinositol signalling system (p = 0.03, 4 genes), in addition to cancer pathways.